Summary Background The Pfizer-BioNTech (BNT162b2) and the Oxford-AstraZeneca
(ChAdOx1 nCoV-19) COVID-19 vaccines have shown excellent safety and efficacy in phase …

Summary Background The SARS-CoV-2 variant of concern, omicron, appears to be less
severe than delta. We aim to quantify the differences in symptom prevalence, risk of hospital …

Background With the surge of new SARS-CoV-2 variants, countries have begun offering
COVID-19 vaccine booster doses to high-risk groups and, more recently, to the adult …

Personalised dietary modulation of the gut microbiota may be key to disease management.
Current investigations provide a broad understanding of the impact of diet on the …

Background Acetate is a short-chain fatty acid (SCFA) produced by gut bacteria, which has
been implicated in cardio-metabolic health. Here we examine the relationships of circulating …

Objectives Dietary supplements may ameliorate SARS-CoV-2 infection, although scientific
evidence to support such a role is lacking. We investigated whether users of the COVID-19 …

Background Individuals with CKD are at a higher risk of cardiovascular morbidity and
mortality. Acidosis is positively correlated with CKD progression and elevated systolic BP …

Epidemiologic and genomic studies have progressively improved our understanding of the
causation of hypertension and the complex relationship with diet and environment. The …

The optimal dietary pattern to improve metabolic function remains elusive. In a 21-day
randomized controlled inpatient crossover feeding trial of 20 insulin-resistant obese women …

Aims/hypothesis The gut microbiome is hypothesised to be related to insulin resistance and
other metabolic variables. However, data from population-based studies are limited. We …